Events & Presentations

Investors

Events & Presentations

Upcoming Events
More events are coming soon.
Archived Events
Date Event Details
Jun 21, 2019
Alpha-1 National Conference
Orlando, FL
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “ARO-AAT for Liver Disease in Alpha-1 Antitrypsin Deficiency: Progress in Clinical Development”
Jun 8, 2019 2:30 PM +08
Science of HBV Cure 2019
Singapore
Bruce Give, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “RNAi: Pulling Us Toward Finite Therapy”
Jun 6, 2019 9:30 AM EDT
Jefferies 2019 Global Health Care Conference
New York, NY
Vincent Anzalone, CFA, Arrowhead’s vice president of investor relations, will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies research analyst
May 23, 2019 8:30 AM PDT
20ᵀᴴ Annual B. Riley FBR Institutional Investor Conference
Beverly Hills
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
May 18, 2019 11:25 AM EDT
2019 National Lipid Association Scientific Sessions
Aventura, FL

So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3”

May 15, 2019 8:40 AM PDT
Bank of America Merrill Lynch 2019 Health Care Conference
Las Vegas, Nevada
Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
May 15, 2019 11:00 AM EDT
Vascular Discovery: From Genes to Medicine 2019 Scientific Sessions (ATVB|PVD)
Boston

So Wong, Ph.D., Arrowhead’s director of biology, will deliver a poster presentation titled, “Reduction in Angiopoietin-Like Protein 3 via RNA Interference Improves Dyslipidemias and Hepatic Steatosis”

May 8, 2019 4:30 PM EDT
Arrowhead Pharmaceuticals 2019 Second Quarter Results
Apr 10, 2019
The EASL International Liver Congress 2019

Oral Presentation:
Short term RNA interference therapy in chronic hepatitis B using JNJ-3989 brings majority of patients to HBsAg <100 IU/mL threshold

  • Presentation Reference: PS-080
  • Session: Parallel session: Hepatitis B - drug development
  • Date and Time: April 12, 2019 at 5:45 p.m. CET
  • Authors: Man-Fung Yuen, et al.

Poster Presentation:
Reduction of hepatic Z-alpha1 antitrypsin by RNA interference (RNAi) prevents and reverses liver disease including hepatic mitochondrial injury in the PiZ mouse model

  • Presentation Reference: FRI-446
  • Session: Poster: Rare liver diseases (including pediatric and genetic)
  • Session Date and Time: April 12, 2019 from 9 a.m. to 5 p.m. CET
  • Authors: Christine Wooddell, et al.
Apr 3, 2019 8:00 AM EDT
AACR Annual Meeting 2019
So Wong, Ph.D., Arrowhead’s director of oncology, will deliver a poster presentation titled, “Optimizing the potency and dosing design for ARO-HIF2: An RNAi therapeutic for clear cell renal cell carcinoma”